van den Berge M - Search Results

1

Phenotypic and functional translation of IL1RL1 locus polymorphisms in lung tissue and asthmatic airway epithelium.

Portelli MA, Dijk FN, Ketelaar ME, Shrine N, Hankinson J, Bhaker S, Grotenboer NS, Obeidat M, Henry AP, Billington CK, Shaw D, Johnson SR, Pogson ZE, Fogarty A, McKeever TM, Nickle DC, Bossé Y, van den Berge M, Faiz A, Brouwer S, Vonk JM, de Vos P, Brandsma CA, Vermeulen CJ, Singapuri A, Heaney LG, Mansur AH, Chaudhuri R, Thomson NC, Holloway JW, Lockett GA, Howarth PH, Niven R, Simpson A, Blakey JD, Tobin MD, Postma DS, Hall IP, Wain LV, Nawijn MC, Brightling CE, Koppelman GH, Sayers I. Portelli MA, et al. Among authors: van den berge m. JCI Insight. 2020 Apr 23;5(8):e132446. doi: 10.1172/jci.insight.132446. JCI Insight. 2020. PMID: 32324168 Free PMC article.

2

Provocation with adenosine 5'-monophosphate increases sputum eosinophils.

van den Berge M, Kerstjens HA, de Reus DM, Kauffman HF, Koëter GH, Postma DS. van den Berge M, et al. Chest. 2003 Mar;123(3 Suppl):417S. Chest. 2003. PMID: 12629008 Review. No abstract available.

3

The role of endogenous and exogenous AMP in asthma and chronic obstructive pulmonary disease.

van den Berge M, Polosa R, Kerstjens HA, Postma DS. van den Berge M, et al. J Allergy Clin Immunol. 2004 Oct;114(4):737-46. doi: 10.1016/j.jaci.2004.05.071. J Allergy Clin Immunol. 2004. PMID: 15480309 Review.

4

Role of adenosine receptors in the treatment of asthma and chronic obstructive pulmonary disease: recent developments.

van den Berge M, Hylkema MN, Versluis M, Postma DS. van den Berge M, et al. Drugs R D. 2007;8(1):13-23. doi: 10.2165/00126839-200708010-00002. Drugs R D. 2007. PMID: 17249846 Review.

5

Inhaled corticosteroids in chronic obstructive pulmonary disease: a review.

Telenga ED, Kerstjens HA, Postma DS, Ten Hacken NH, van den Berge M. Telenga ED, et al. Among authors: van den berge m. Expert Opin Pharmacother. 2010 Feb;11(3):405-21. doi: 10.1517/14656560903510628. Expert Opin Pharmacother. 2010. PMID: 20102305 Review.

6

Beneficial effects of treatment with anti-IgE antibodies (Omalizumab) in a patient with severe asthma and negative skin-prick test results.

van den Berge M, Pauw RG, de Monchy JG, van Minnen CA, Postma DS, Kerstjens HA. van den Berge M, et al. Among authors: van minnen ca. Chest. 2011 Jan;139(1):190-3. doi: 10.1378/chest.10-0128. Chest. 2011. PMID: 21208879

7

Small airway disease in asthma and COPD: clinical implications.

van den Berge M, Ten Hacken NHT, Cohen J, Douma WR, Postma DS. van den Berge M, et al. Chest. 2011 Feb;139(2):412-423. doi: 10.1378/chest.10-1210. Chest. 2011. PMID: 21285055 Review.

8

Small airway disease in asthma: a need for awareness in patients and doctors.

van den Berge M, ten Hacken NH, Postma DS. van den Berge M, et al. Clin Respir J. 2011 Jul;5(3):123-4. doi: 10.1111/j.1752-699X.2011.00249.x. Clin Respir J. 2011. PMID: 21679347 No abstract available.

9

Genetics of glucocorticoids in asthma.

van den Berge M, Hiemstra PS, Postma DS. van den Berge M, et al. N Engl J Med. 2011 Dec 22;365(25):2434-5; author reply 2435-6. doi: 10.1056/NEJMc1112547. N Engl J Med. 2011. PMID: 22187996 No abstract available.

10

Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD.

van den Berge M, Vonk JM, Gosman M, Lapperre TS, Snoeck-Stroband JB, Sterk PJ, Kunz LI, Hiemstra PS, Timens W, Ten Hacken NH, Kerstjens HA, Postma DS. van den Berge M, et al. Eur Respir J. 2012 Nov;40(5):1098-105. doi: 10.1183/09031936.00169711. Epub 2012 Apr 20. Eur Respir J. 2012. PMID: 22523354 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

427 results

Search Page